DG5 SonoVue (sulphur hexafluoride microbubbles) - contrast agent for contrast-enhanced ultrasound imaging of the liver: understanding NICE guidance

NICE has assessed SonoVue to help the NHS decide whether to use this product.

SonoVue is a substance that is injected into the bloodstream to help make ultrasound pictures clearer. NICE looked at SonoVue when it is used with ultrasound to look at the liver. It can give doctors more information about abnormal-looking areas in the liver than normal ultrasound, which can help with the diagnosis.

NICE has said that SonoVue is recommended for use with ultrasound for examining abnormal-looking areas in the liver that are seen, but cannot be properly identified, using normal ultrasound. These areas may have been unexpectedly found in a liver scan. If they were seen when looking for cancer that has spread from another part of the body, SonoVue is recommended if the person cannot have or strongly does not want a CT (computed tomography) scan. If they were seen in someone with cirrhosis who is having their liver checked, SonoVue is recommended if the person cannot have or strongly does not want an MRI (magnetic resonance imaging) scan.

This page was last updated: 30 August 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.